302. レーベル遺伝性視神経症 Leber hereditary optic neuropathy Clinical trials / Disease details
臨床試験数 : 23 / 薬物数 : 15 - (DrugBank : 5) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 33
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03153293 (ClinicalTrials.gov) | December 27, 2017 | 10/5/2017 | A Single Intravitreal Injection of rAAV2-ND4 for the Treatment of Leber's Hereditary Optic Neuropathy | A Single Intravitreal Injection of rAAV2-ND4 for the Treatment of Leber's Hereditary Optic Neuropathy | Leber Hereditary Optic Neuropathy | Drug: rAAV2-ND4 | Huazhong University of Science and Technology | Shiyan Taihe Hospital | Active, not recruiting | 10 Years | 65 Years | All | 159 | Phase 2/Phase 3 | China |
| 2 | NCT01267422 (ClinicalTrials.gov) | April 2011 | 27/12/2010 | Safety and Efficacy Study of rAAV2-ND4 Treatment of Leber Hereditary Optic Neuropathy (LHON) | Safety and Efficacy Study of a Single Intravitreal Injection of rAAV2-ND4 Treatment of Leber Hereditary Optic Neuropathy | Leber Hereditary Optic Neuropathy | Drug: rAAV2-ND4 | Bin Li | Huazhong University of Science and Technology | Completed | 8 Years | 60 Years | All | 9 | N/A | China |